Binedaline

CAS : 60662-16-0

Ref. 3D-KCA66216

Informations sur le produit

• Nom: Binedaline
• Synonymes: 1,2-Ethanediamine, N,N,N'-trimethyl-N'-(3-phenyl-1H-indol-1-yl)-, 1,2-Ethanediamine, N¹,N¹,N²-trimethyl-N²-(3-phenyl-1H-indol-1-yl)-, 1-((2-(Dimethylamino)ethyl)methylamino)-3-phenylindole, Binedalina, Binedalina [INN-Spanish], Binedalina [Spanish], Binedaline [INN], Binedalinum, Binedalinum [INN-Latin], Binedalinum [Latin], Binodalina, Binodalina [INN-Spanish], Binodaline, Binodalinum, Binodalinum [INN-Latin], Brn 1653944, N,N,N'-trimethyl-N'-(3-phenyl-1H-indol-1-yl)ethane-1,2-diamine, N¹,N¹,N²-Trimethyl-N²-(3-phenyl-1H-indol-1-yl)-1,2-ethanediamine, Sgd scha 1509 (siegfried), Unii-3Avg9P140R

Description

Binedaline is a potent anticancer drug that targets human kinases, which are proteins involved in cell signaling pathways. It is an analog of a medicinal compound found in Chinese urine and has been shown to induce apoptosis (programmed cell death) in tumor cells. Binedaline works by inhibiting kinases, which play a critical role in the growth and survival of cancer cells. By blocking these kinases, Binedaline prevents the cancer cells from proliferating and induces their death. This drug is a promising candidate for the treatment of various types of cancer and has shown great potential as a kinase inhibitor.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 293.4 g/mol
• Formule: C₁₉H₂₃N₃
• Degré de pureté: Min. 95%